Proposed cap on trade margins will not hurt pharma cos
Citing media reports Fitch said, the National Pharmaceutical Pricing Authority is making progress in reaching a consensus with…
Author
Cipla shares rise marginally post agreement with CitiHealth Imports
On the BSE, the stock hit intra-day high of Rs 476.35, up 1.83 per cent. It settled 0.22 per cent up at Rs 468.80. On the BSE, the…
Cipla arm to acquire remaining stake in Cipla Pharma Lanka
Cipla (EU) already has a 60 per cent stake in Cipla Pharma Lanka Pvt Ltd. Post-acquisition, Cipla Pharma Lanka will become a…
Glenmark Pharma gets USFDA nod for diabetes management drug
The company's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new…
Chinese strategy: Dr Reddy’s outsources part manufacturing to local parties
The company which won the tender to market Olanzapine drug in China, is expected to launch it beginning next year, the official…
Aurobindo Pharma aims to become debt free in three years sans Sandoz deal
In September last year, the $3 billion drug maker said its US subsidiary entered into an agreement to acquire commercial…
Zydus Cadila gets US FDA nod for Isosorbide Dinitrate tablets, Desonide Cream
The drug firm has also received final approval from US health regulator for Desonide Cream, used to treat a variety of skin…
Glenmark recalls over two lakh cartons of product in US
According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals Inc USA is…
Ajanta Pharma Q2 net profit dips 7 to Rs 116 crore
Income from operations rose to Rs 643 crore during the period under review, as compared with Rs 544 crore in the year-ago period
Cadila Healthcare gets EIR from US FDA for Baddi facility
The United States Food and Drug Administration (US FDA) had conducted an inspection at the facility from July 15 to 19, 2019,"…